The founder and former leader of Inhibikase Therapeutics is blazing a new biotech trail in an effort to get a beleaguered ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost ...

Azafaros has secured 132 million euros ($147 million) in series B funds that the Dutch biotech will use to push its rare ...

Azithromycin has been widely evaluated for its efficacy against COVID-19. The study by Timothy S C Hinks and colleagues1 adds value to the current literature, and we would like to share our comments.

Bactana Corp., a biotech startup headquartered at UConn’s Technology Incubation Program in Farmington, announced Tuesday it ...

or biotech startup Treeline Biosciences find new drug candidates by simulating molecules. Sign up here. Its software was originally written with central processor units, or CPUs, in mind during an ...

Matthew Herper joins Adam and Allison to examine Prasad’s appointment and the band of outsiders now in charge of U.S. health ...

We are transferring coverage of Sartorius AG and its subsidiary Sartorius Stedim Biotech—both active in biopharmaceutical equipment and laboratory consumables—to a new analyst. Sartorius ...

The Trump administration’s sweeping cuts of federal research funding and its fight with Harvard University risk bleeding into the venture capital market, curbing financing opportunities for ...

The third of its kind from Deerfield ... Those investments were tallied during a recalibration of biotech venture funding, with venture firms coalescing around a smaller number of surer bets ...